GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » PB Ratio

Jacobio Pharmaceuticals Group Co (HKSE:01167) PB Ratio : 1.20 (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Jacobio Pharmaceuticals Group Co's share price is HK$1.78. Jacobio Pharmaceuticals Group Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.48. Hence, Jacobio Pharmaceuticals Group Co's PB Ratio of today is 1.20.

Good Sign:

Jacobio Pharmaceuticals Group Co Ltd stock PB Ratio (=1.05) is close to 5-year low of 0.98

The historical rank and industry rank for Jacobio Pharmaceuticals Group Co's PB Ratio or its related term are showing as below:

HKSE:01167' s PB Ratio Range Over the Past 10 Years
Min: 0.98   Med: 3.03   Max: 8.72
Current: 1.2

During the past 6 years, Jacobio Pharmaceuticals Group Co's highest PB Ratio was 8.72. The lowest was 0.98. And the median was 3.03.

HKSE:01167's PB Ratio is ranked better than
76.56% of 1310 companies
in the Biotechnology industry
Industry Median: 2.535 vs HKSE:01167: 1.20

During the past 12 months, Jacobio Pharmaceuticals Group Co's average Book Value Per Share Growth Rate was -20.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -19.00% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Jacobio Pharmaceuticals Group Co was -19.00% per year. The lowest was -19.00% per year. And the median was -19.00% per year.

Back to Basics: PB Ratio


Jacobio Pharmaceuticals Group Co PB Ratio Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co PB Ratio Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 5.07 5.58 2.82 2.44

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.58 2.65 2.82 3.38 2.44

Competitive Comparison of Jacobio Pharmaceuticals Group Co's PB Ratio

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobio Pharmaceuticals Group Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's PB Ratio falls into.



Jacobio Pharmaceuticals Group Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Jacobio Pharmaceuticals Group Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.78/1.483
=1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Jacobio Pharmaceuticals Group Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Shen Zhu 2501 Other
Treasure Partner International Limited 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Yakovpharma Ltd 2501 Other
Willgenpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Johwpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines